News

Back to All News

Tandem Diabetes Care, Inc. (TNDM) - Initiation of Research Coverage

June 18, 2018

Lake Street Capital Markets Analyst Brooks O’Neil initiated coverage of Tandem Diabetes Care, Inc. (TNDM), with a BUY rating and price target of $30.00 (TNDM $19.91). Tandem is an innovative developer of pumps and other products for people with insulin-dependent diabetes.

Contact Us

Phone
612.326.1305

US Mail
920 Second Avenue South
Suite 700
Minneapolis, MN 55402

Email
Email Us

Find Us